Financhill
Sell
47

CACI Quote, Financials, Valuation and Earnings

Last price:
$483.23
Seasonality move :
7.06%
Day range:
$479.58 - $485.00
52-week range:
$318.60 - $588.26
Dividend yield:
0%
P/E ratio:
22.79x
P/S ratio:
1.30x
P/B ratio:
2.87x
Volume:
104K
Avg. volume:
247.4K
1-year change:
8.19%
Market cap:
$10.6B
Revenue:
$7.7B
EPS (TTM):
$21.19

Earnings Data

Next earnings date for CACI
Aug 06
2025
Most recent earnings per share
$5.00
Missed by $0.60
(Apr 24/2025)
Consensus Estimate
$5.60
(Apr 24/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CACI Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
09/30/2025 Q3 $2.3B -- -- $6.41 --
08/06/2025 Q2 $2.3B -- -- $6.62 --
04/24/2025 Q1 $2.1B $2.2B $5.00 $5.60 -$0.60
01/22/2025 Q4 $2B $2.1B $4.88 $5.20 -$0.32
10/23/2024 Q3 $1.9B $2.1B $5.33 $5.04 $0.29
08/07/2024 Q2 $1.9B $2B $5.98 $5.93 $0.05
04/24/2024 Q1 $1.9B $1.9B $5.13 $5.54 -$0.41
01/25/2024 Q4 $1.8B $1.8B $3.74 $4.48 -$0.74
10/25/2023 Q3 $1.7B $1.9B $3.76 $4.55 -$0.79
08/09/2023 Q2 $1.7B $1.7B $4.68 $4.90 -$0.22
04/26/2023 Q1 -- $1.7B $4.33 -- --
01/25/2023 Q4 -- $1.6B $3.68 -- --
10/26/2022 Q3 -- $1.6B $3.76 -- --
08/10/2022 Q2 -- $1.6B $3.93 -- --
04/27/2022 Q1 -- $1.6B $4.04 -- --
01/26/2022 Q4 -- $1.5B $3.83 -- --
10/27/2021 Q3 -- $1.5B $3.70 -- --
08/11/2021 Q2 -- $1.6B $5.74 -- --
04/21/2021 Q1 -- $1.6B $4.78 -- --
01/27/2021 Q4 -- $1.5B $4.18 -- --
10/28/2020 Q3 -- $1.5B $3.67 -- --
08/12/2020 Q2 -- $1.5B $3.68 -- --
04/29/2020 Q1 -- $1.5B $3.16 -- --
01/29/2020 Q4 -- $1.4B $3.11 -- --
10/30/2019 Q3 -- $1.4B $2.66 -- --
08/14/2019 Q2 -- $1.4B $1.96 -- --
05/01/2019 Q1 -- $1.3B $2.69 -- --
01/30/2019 Q4 -- $1.2B $2.71 -- --
10/31/2018 Q3 -- $1.2B $3.10 -- --
08/15/2018 Q2 -- $1.2B $2.05 -- --
05/02/2018 Q1 -- $1.1B $2.56 -- --
01/31/2018 Q4 -- $1.1B $5.66 -- --
11/01/2017 Q3 -- $1.1B $1.67 -- --
08/16/2017 Q2 -- $1.1B $1.76 -- --
05/03/2017 Q1 -- $1.1B $1.61 -- --
02/02/2017 Q4 -- $1.1B $1.69 -- --
10/27/2016 Q3 -- $1.1B $1.47 -- --
08/17/2016 Q2 -- $1.1B $1.75 -- --
04/28/2016 Q1 -- $977.3M $1.38 -- --
02/04/2016 Q4 -- $830.4M $1.23 -- --
10/29/2015 Q3 -- $822.4M $1.40 -- --

CACI International Earnings Questions

  • How Much did CACI International Generate in Revenue Last Quarter?

    CACI International reported $2.2B worth of top line sales in its most recent quarter.

  • Did CACI International Beat Earnings Last Quarter?

    CACI International announced earnings per share of $5.00 which represents a miss of analyst forecast a $5.60 per share.

  • Is CACI International Profitable?

    CACI International reported $196.4M that represents $8.77 per share over the last quarter.

  • What is the Analyst Consensus for CACI International EPS Next Year?

    CACI International's earnings are forecast to grow from $18.60 per share to $24.62 per share next year representing an increase of 47.57%.

  • When is CACI International's Earnings Date?

    CACI International's next earnings date is August 6, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Bloom Energy Flying Under the Radar?
Is Bloom Energy Flying Under the Radar?

Bloom Energy (NYSE:BE) manufactures scalable fuel cells for providing on-site…

Will GoodRX Stock Bounce Back?
Will GoodRX Stock Bounce Back?

GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…

Will FCX Benefit From Tariffs?
Will FCX Benefit From Tariffs?

Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…

Stock Ideas

Buy
70
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 59x

Buy
61
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
55
TLN alert for Jul 19

Talen Energy [TLN] is up 24.44% over the past day.

Sell
48
CRSP alert for Jul 19

CRISPR Therapeutics AG [CRSP] is up 18.22% over the past day.

Buy
83
SOC alert for Jul 19

Sable Offshore [SOC] is up 11.86% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock